CAS No. |
898537-18-3 |
中文名称 |
(2S,3R,4R,5S,6R)-2-(5-(4-乙氧基苄基)-2-甲氧基-4-甲基苯基)-6-(羟甲基)四氢-2H-噻喃-3,4,5-三醇 |
英文名称 |
(2S,3R,4R,5S,6R)-2-(5-(4-ethoxybenzyl)-2-methoxy-4-methylphenyl)-6-(hydroxymethyl)tetrahydro-2H-thiopyran-3,4,5-triol |
别名 |
Luseogliflozin,D-Glucitol, 1,5-dideoxy-1,5-epithio-1-C-[5-[(4-ethoxyphenyl)Methyl]-2-Methoxy-4-Methylphenyl]-, (1S)-;D-Glucitol, 1,5-dideoxy-1,5-epithio-1-C-[5-[(4-ethoxyphenyl)Methyl]-2-Methoxy-4-Methylphenyl]-, (1S)-;Luseogliflozin;(1S)-1,5-Dideoxy-1,5-epithio-1-C-[5-[(4-ethoxyphenyl)methyl]-2-methoxy-4-methylphenyl]-D-glucitol;TS 071;(2S,3R,4R,5S,6R)-2-[5-[(4-ethoxyphenyl)methyl]-2-methoxy-4-methylphenyl]-6-(hydroxymethyl)thiane-3,4,5-triol;TS 071; TS071; TS-71;TS-71 |
标准英文名 |
(2S,3R,4R,5S,6R)-2-(5-(4-ethoxybenzyl)-2-methoxy-4-methylphenyl)-6-(hydroxymethyl)tetrahydro-2H-thiopyran-3,4,5-triol |
分子式 |
C23H30O6S |
分子量 |
434.18
|
精确分子量 |
434.18
|
SMILES |
COC1=C([C@@H]2S[C@@H]([C@H]([C@@H]([C@H]2O)O)O)CO)C=C(C(C)=C1)CC3=CC=C(C=C3)OCC |
标准SMILES |
CC1=CC(OC)=C(C=C1CC1=CC=C(C=C1)OCC)[C@@H]1S[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O |
用途 |
Luseogliflozin is a sodium-glucose cotransporter 2 (SGLT2) inhibitor developed by Daiichi Sankyo Co., Ltd. for the treatment of type 2 diabetes mellitus. It lowers blood glucose levels by inhibiting SGLT2 in the proximal renal tubules, thereby reducing renal glucose reabsorption, lowering the renal threshold for glucose (RTG), and increasing urinary glucose excretion. As an SGLT2 inhibitor, it promotes glucosuria without causing weight gain or hypoglycemia, representing a novel class of antidiabetic agents. |
InChIKey |
WHSOLWOTCHFFBK-ZQGJOIPISA-N |